Literature DB >> 18627279

A qualitative examination of the indirect effects of modified directly observed therapy on health behaviors other than adherence.

Andrea Bradley-Ewing1, Domonique Thomson, Megan Pinkston, Kathy J Goggin.   

Abstract

Modified directly observed therapy (mDOT), in which a portion of doses in a medication regimen are ingested under supervision, has had some demonstrated success in improving the high levels of adherence necessary to achieve maximum benefit from antiretroviral medications. Consistent with the Information-Motivation-Behavioral skills (IMB) model, mDOT's success is likely due to its direct impact on patients' knowledge, motivation, and behaviors related to adherence. However, mDOT's potential impact on patients' information, motivation, and behaviors related to health activities other than adherence to antiretroviral medications has not been explored. Data from participants enrolled in Project MOTIV8, a randomized controlled trial to test the efficacy of novel behavioral adherence interventions, were analyzed to explore the potential impact of mDOT on health behaviors other than adherence. Participants were recruited from local HIV clinics from 2004-2008. Thirty-four percent of those approached, agreed to participate in the study. Data from all participants randomized to the mDOT intervention arm thus far (n = 50, mean age 39.7 standard deviation [SD] = 9.0, 78% male 64% African American, and 86% infected via sexual transmission) were included. Overall, participants reported a high level of satisfaction with the mDOT intervention. Qualitative data revealed that mDOT had a positive impact on participants' adherence to nonantiretroviral medications as well as their involvement and communication with health care providers. In addition, participants reported that the daily mDOT visits had indirect effects on their daily functioning, including improvements in their daily living activities (e.g., earlier awakenings, getting dressed, and cleaning their homes) and an increased level of community involvement.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18627279      PMCID: PMC2929153          DOI: 10.1089/apc.2007.0190

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  36 in total

1.  Directly observed therapy in HIV therapy: A realistic perspective?

Authors:  M Lanzafame; M Trevenzoli; A M Cattelan; P Rovere; A Parrinello
Journal:  J Acquir Immune Defic Syndr       Date:  2000-10-01       Impact factor: 3.731

2.  Directly observed therapy to treat HIV infection in prisoners.

Authors:  S Babudieri; A Aceti; G P D'Offizi; S Carbonara; G Starnini
Journal:  JAMA       Date:  2000-07-12       Impact factor: 56.272

3.  Enhancing adherence to HAART: a pilot program of modified directly observed therapy.

Authors:  M S Stenzel; M McKenzie; J A Mitty; T P Flanigan
Journal:  AIDS Read       Date:  2001-06

4.  Adherence to protease inhibitor therapy and outcomes in patients with HIV infection.

Authors:  D L Paterson; S Swindells; J Mohr; M Brester; E N Vergis; C Squier; M M Wagener; N Singh
Journal:  Ann Intern Med       Date:  2000-07-04       Impact factor: 25.391

5.  Quality of life measures in the Miami HIV-1 infected drug abusers cohort: relationship to gender and disease status.

Authors:  G Shor-Posner; R Lecusay; M J Miguez-Burbano; J Quesada; A Rodriguez; P Ruiz; S O'Mellan; A Campa; H Rincon; F Wilkie; J B Page; M K Baum
Journal:  J Subst Abuse       Date:  2000

6.  Adherence to antiretroviral medications in an inner-city population.

Authors:  P J Weidle; C E Ganera; K L Irwin; J P McGowan; J A Ernst; N Olivo; S D Holmberg
Journal:  J Acquir Immune Defic Syndr       Date:  1999-12-15       Impact factor: 3.731

Review 7.  Directly observed therapy for the treatment of tuberculosis--evidence based dosage guidelines.

Authors:  R Bednall; G Dean; N Bateman
Journal:  Respir Med       Date:  1999-11       Impact factor: 3.415

Review 8.  Factors affecting adherence to antiretroviral therapy.

Authors:  M A Chesney
Journal:  Clin Infect Dis       Date:  2000-06       Impact factor: 9.079

Review 9.  Addressing the challenges of adherence.

Authors:  J A Bartlett
Journal:  J Acquir Immune Defic Syndr       Date:  2002-02-01       Impact factor: 3.731

10.  Adherence, drug use, and treatment failure in a methadone-clinic-based program of directly administered antiretroviral therapy.

Authors:  Gregory M Lucas; B Anna Mullen; Mary E McCaul; Paul J Weidle; Shannon Hader; Richard D Moore
Journal:  AIDS Patient Care STDS       Date:  2007-08       Impact factor: 5.078

View more
  4 in total

1.  Community-based DOT-HAART accompaniment in an urban resource-poor setting.

Authors:  Maribel Muñoz; Karen Finnegan; Jhon Zeladita; Adolfo Caldas; Eduardo Sanchez; Miriam Callacna; Christian Rojas; Jorge Arevalo; Jose Luis Sebastian; Cesar Bonilla; Jaime Bayona; Sonya Shin
Journal:  AIDS Behav       Date:  2009-04-16

Review 2.  Effect of directly observed therapy for highly active antiretroviral therapy on virologic, immunologic, and adherence outcomes: a meta-analysis and systematic review.

Authors:  Jessica E Hart; Christie Y Jeon; Louise C Ivers; Heidi L Behforouz; Adolfo Caldas; Peter C Drobac; Sonya S Shin
Journal:  J Acquir Immune Defic Syndr       Date:  2010-06       Impact factor: 3.731

3.  How does directly observed therapy work? The mechanisms and impact of a comprehensive directly observed therapy intervention of highly active antiretroviral therapy in Peru.

Authors:  Sonya Shin; Maribel Muñoz; Jhon Zeladita; Sam Slavin; Adolfo Caldas; Eduardo Sanchez; Miriam Callacna; Christian Rojas; Jorge Arevalo; Jose Luis Sebastian; Jaime Bayona
Journal:  Health Soc Care Community       Date:  2010-12-08

4.  How treatment partners help: social analysis of an African adherence support intervention.

Authors:  Kelli N O'Laughlin; Monique A Wyatt; Sylvia Kaaya; David R Bangsberg; Norma C Ware
Journal:  AIDS Behav       Date:  2012-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.